Cas:4221-68-5 4,4′-Cyclohexane-1,1-diylbis(2-cyclohexylphenol) manufacturer & supplier

Chemical Name:4,4′-Cyclohexane-1,1-diylbis(2-cyclohexylphenol)

CAS.NO:4221-68-5

Synonyms:4,4′-Cyclohexane-1,1-diylbis(2-cyclohexylphenol);Phenol, 4,4′-cyclohexylidenebis[2-cyclohexyl-;4,4′-Cyclohexylidenebis(2-cyclohexylphenol);4,4′-(1,1-Cyclohexanediyl)bis(2-cyclohexylphenol);2-cyclohexyl-4-[1-(3-cyclohexyl-4-hydroxyphenyl)cyclohexyl]phenol;1,1-Bis(3-cyclohexyl-4-hydroxyphenyl)cyclohexane

Molecular Formula:C₃₀H₄₀O₂

Molecular Weight:432.637

HS Code:2907299090

Physical and Chemical Properties:

Melting point:166ºC

Boiling point:507.0±50.0 °C at 760 mmHg

Density:1.1±0.1 g/cm3

Index of Refraction:1.587

PSA:40.46000

Exact Mass:432.302826

LogP:9.57

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 4,4′-Cyclohexane-1,1-diylbis(2-cyclohexylphenol) chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1,1-Bis(3-cyclohexyl-4-hydroxyphenyl)cyclohexane physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4,4′-(1,1-Cyclohexanediyl)bis(2-cyclohexylphenol) Use and application,4,4′-Cyclohexane-1,1-diylbis(2-cyclohexylphenol) technical grade,usp/ep/jp grade.

Related News: The iLet is designed to function as three medical devices in one. It can be configured as an insulin-only bionic pancreas, a glucagon-only bionic pancreas, or a bihormonal bionic pancreas using insulin and glucagon. 4,4′-Cyclohexane-1,1-diylbis(2-cyclohexylphenol) manufacturer A Phase 1/2 trial of the combination therapy has been fully enrolled, and the preliminary efficacy and safety data was presented at The American Society of Hematology (ASH) Annual Meeting in December 2018. 4,4′-Cyclohexane-1,1-diylbis(2-cyclohexylphenol) supplier The company-backed investigation was based on interviews with more than 100 people, the May 20 memo to Lilly employees said. However, the memo did not respond to all concerns employees raised in their April complaint, which Reuters reviewed. 4,4′-Cyclohexane-1,1-diylbis(2-cyclohexylphenol) vendor Huahai started with the development of characteristic APIs and pharmaceutical intermediates. At the same time, using the international cooperation platform and the opportunity of the expiry of patent protection of major international original research drugs, Huahai has extended the industrial chain to downstream high value-added preparations, and formed intermediates and materials The complete industrial chain of medicine and preparation integration. 4,4′-Cyclohexane-1,1-diylbis(2-cyclohexylphenol) factory Huahai started with the development of characteristic APIs and pharmaceutical intermediates. At the same time, using the international cooperation platform and the opportunity of the expiry of patent protection of major international original research drugs, Huahai has extended the industrial chain to downstream high value-added preparations, and formed intermediates and materials The complete industrial chain of medicine and preparation integration.